Trifluoperazine Hydrochloride and Victrelis

• Generic Name: trifluoperazine
• Dosage Forms: n.a.
• Other Brand Names: Stelazine

Treatment of schizophrenia.

American Psychiatric Association (APA) considers most atypical antipsychotic agents first-line drugs for management of the acute phase of schizophrenia (including first psychotic episodes). APA considers conventional antipsychotic agents first-line in patients with acute psychotic episodes who have been treated successfully in the past with, or who prefer, conventional agents.

Patients who do not respond to or tolerate one drug may be successfully treated with an agent from a different class or with a different adverse effect profile.

Short-term management of nonpsychotic anxiety in patients with generalized anxiety disorder.

Not established whether trifluoperazine is useful for the management of other nonpsychotic conditions in which anxiety or manifestations that mimic anxiety are evident (e.g., physical illness, organic mental conditions, agitated depression, character pathologies).

Because of the risks of toxicity, use only as an alternative to other less toxic anxiolytic agents (e.g., benzodiazepines) in most patients.

Efficacy not established for the management of behavioral complications in patients with mental retardation.

• Generic Name: boceprevir
• Dosage Forms: capsule
• Other Brand Names: Victrelis

Victrelis (boceprevir) is an antiviral medicine that prevents certain viruses from multiplying in your body.

Victrelis is used in combination with peginterferon alfa and ribavirin, or with sofosbuvir to treat hepatitis C genotype 1 in adults.

Read the medication guide or patient instructions provided with each medication in your combination therapy. Do not change your doses or medication schedule without your doctor's advice.

Victrelis may also be used for purposes not listed in this medication guide.